PTK 2015 Banner 
2015 Peptalk M Banner 

Pipeline Two Header

The field of antibody-based therapeutics remains ripe for exploration as it encompasses novel developments for cancer, antibody-drug conjugates and bispecific antibodies. The weeklong Antibody Therapeutics pipeline divulges R&D strategies, clinical results and efficacy data and reveals the intricacies of these promising molecules as well as the exciting results that international research efforts have achieved.

Conferences Include:

January 19-20

Cancer Targets for Antibody Therapeutics 

January 21-22

Antibody-Drug Conjugates 

January 22-23

Bispecific Antibody Therapeutics 


SC1: Production Challenges for Complex Biologics: ADCs, Bispecifics and Fusion Proteins  

SC2: The S-Score System: A Tool for Identifying New Cancer Targets for Antibody-Drug Therapy 

SC8: Affecting Effector Function: Engineering the Fc Region 

*Separate registration required. Click here for more details.